Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Birner

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Neuro-Oncology|May 13, 2017
Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutationsS Balendran, S Liebmann-Reindl, A S Berghoff, et al.
The British Journal of Surgery|May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastasesS F Schoppmann, B Jesch, J Zacherl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancerP Birner, G Oberhuber, J Stani, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2014
Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastasesA S Berghoff, A Ilhan-Mutlu, A Wöhrer, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
European Journal of Cancer Care|May 11, 2017
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patientsE K Masel, A S Berghoff, L M Füreder, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Neuro-Oncology|May 13, 2017
Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutationsS Balendran, S Liebmann-Reindl, A S Berghoff, et al.
The British Journal of Surgery|May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastasesS F Schoppmann, B Jesch, J Zacherl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancerP Birner, G Oberhuber, J Stani, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 2014
Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastasesA S Berghoff, A Ilhan-Mutlu, A Wöhrer, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
European Journal of Cancer Care|May 11, 2017
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patientsE K Masel, A S Berghoff, L M Füreder, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Pageof 6